Free Trial

Protagonist Therapeutics (PTGX) SEC Filings & 10K Form

Protagonist Therapeutics logo
$41.11 +0.07 (+0.17%)
(As of 11/15/2024 ET)

Recent Protagonist Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
3:27 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:51 PM
Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
3:39 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
12:22 PM
Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/16/2024
11:48 AM
Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
09/13/2024
3:35 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
6:38 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
5:15 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:17 PM
Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
3:18 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
6:08 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:31 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:33 PM
Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
3:12 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
3:30 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:30 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:30 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:46 PM
Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
3:51 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/19/2024
7:05 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:30 PM
Protagonist Therapeutics (Filer)
Form PRE 14A
04/02/2024
7:29 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:45 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:45 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:46 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:27 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:32 PM
Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:48 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
7:00 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:02 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:33 PM
Protagonist Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
7:00 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:31 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/14/2024
6:47 AM
Protagonist Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/14/2024
6:15 AM
Point72 Asset Management, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/13/2024
4:12 PM
Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/07/2024
6:41 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/02/2024
8:19 AM
Farallon Capital Partners, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
01/23/2024
9:55 AM
Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
2024 Election Year Stocks: Uncover Hidden Gems! (Ad)

In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.

Secure your copy now by clicking this link.
01/18/2024
7:00 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
7:00 PM
MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
7:01 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
7:00 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
4:25 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:00 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
7:17 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:07 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:09 PM
MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:10 PM
Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:11 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:13 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:14 PM
Protagonist Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:15 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:17 PM
O'Dowd Sarah A (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:15 PM
Point72 Asset Management, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G
12/15/2023
3:30 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
4:18 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PTGX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners